High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients?

S. Tabur; H. Sezen; H. Korkmaz; M. Ozkaya; E. Akarsu

doi:10.1055/s-0035-1564200

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2016; 124(02): 82-86
DOI: 10.1055/s-0035-1564200

Article

High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients?

Authors

S. Tabur

¹Gaziantep University, Gaziantep, Turkey
H. Sezen

²Faculty of Medicine, Harran University, Sanliurfa, Turkey
H. Korkmaz

³Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
M. Ozkaya

³Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
E. Akarsu

³Faculty of Medicine, Gaziantep University, Gaziantep, Turkey

Abstract

The present study aimed to evaluate the activity of prolidase in controlled acromegaly patients and its association with oxidative stress. 25 acromegalic patients in remission who were followed in our outpatient clinic and 31 healthy controls were enrolled in the study. Serum growth hormone (GH), insulin-like growth factor 1 (IGF-1), total antioxidative status (TAS), total oxidative stress (TOS), total free sulfhydryl (-SH), paraoxonase (PON), arylesterase (ARE), lipid hydroperoxide (LOOH) and prolidase activity levels were measured. Percent ratio of TOS to TAS level was accepted as oxidative stress index (OSI). Serum prolidase activity, TOS, OSI, and LOOH levels were significantly higher in acromegaly patients compared to the healthy control group (p<0.001, p=0.001, p<0.001, and p<0.001, respectively). SH levels were significantly lower in the acromegaly patients compared to the healthy control group (p=0.002). Prolidase activity were positively correlated with TOS, OSI, LOOH and negatively correlated with -SH in patients with acromegaly (r=0.471, p<0.001; r=0.527, p<0.001; r=0.717, p<0.001; r=− 0.516, p<0.001, respectively). These associations were confirmed in the multiple regression analysis (R²=0.502, p<0.001). In conclusion, serum prolidase activity and oxidative stress levels were high in controlled acromegaly patients. These results suggest that extracellular matrix changes continue eventhough the disease is controlled, and elevated oxidative stress is involved in the increased prolidase activity in acromegaly patients.

Key words

acromegaly - extracellular matrix - prolidase - oxidative status

Full Text

References

References
1 Valkusz Z, Tóth M, Boda J et al. The importance of early diagnosis in acromegaly. Orv Hetil 2011; 152: 696-702
2 Wassenaar MJ, Cazemier M, Biermasz NR et al. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab 2010; 95: 2073-2079
3 van der Klaauw AA, Bax JJ, Smit JW et al. Increased aortic root diameters in patients with acromegaly. Eur J Endocrinol 2008; 159: 97-103
4 Antoniazzi F, Monti E, Venturi G et al. GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 2010; 163: 479-487
5 Doessing S, Heinemeier KM, Holm L et al. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol 2010; 588: 341-351
6 Hansen M, Boesen A, Holm L et al. Local administration of insulinlike growth factor-I (IGF-I) stimulates tendon collagen synthesis in humans. Scand J Med Sci Sports 2013; 23: 614-619
7 Vestergaard PF, Jorgensen JOL, Olesen JL et al. Local Administration of Growth Hormone Stimulates Tendon Collagen Synthesis in Elderly Men. J Appl Physiol 2012; 113: 1432-1438
8 Horoz M, Aslan M, Bolukbas FF et al. Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis. J Clin Lab Anal 2010; 24: 207-211
9 Cechowska-Pasko M, Pałka J, Wojtukiewicz MZ. Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol 2006; 87: 289-296
10 Nishizawa H, Handayaningsih AE, Iguchi G et al. Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans. Growth Horm IGF Res 2012; 22: 64-68
11 Tabur S, Aksoy SN, Korkmaz H et al. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol 2014;
12 Uzar E, Tamam Y, Evliyaoglu O et al. Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurological Sciences 2012; 33: 875-880
13 Myara I, Myara A, Mangeot M et al. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clinical Chemistry 1984; 30: 211-215
14 Erbagci AB, Araz M, Erbağci A et al. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clinical Biochemistry 2002; 35: 263-268
15 Savas M, Yeni E, Celik H et al. The association of serum prolidase activity and erectile dysfunction. Journal of Andrology 2010; 31: 146-154
16 Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: Application to imminodipeptiduria. Clin Chim Acta 1982; 125: 193-205
17 Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952; 199: 91-95
18 Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004; 37: 112-119
19 Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38: 1103-1111
20 Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005; 47: 635-639
21 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
22 Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004; 325: 158-163
23 Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-1138
24 Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-395
25 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839
26 Zitka O, Kukacka J, Krizkova S et al. Matrix metalloproteinases. Curr Med Chem 2010; 17: 3751-3768
27 Doessing S, Holm L, Heinemeier KM et al. and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients. Eur J Endocrinol 2010; 163: 853-862
28 Thompson BJ, Shan CA, Waters MJ. Identification of genes induced by growht hormone in rat live using cDNA arrays. Endocrinology 2000; 141: 4321-4324
29 Quatresooz P, Hermanns-Lê T, Ciccarelli A et al. Tensegrity and type 1 dermal dendrocytes in acromegaly. Eur J Clin Invest 2005; 35: 133-139
30 Celik O, Akhan SE, Hatipoglu E et al. Increased incidence of pelvic organ prolapse in women with acromegaly. Eur J Obstet Gynecol Reprod Biol 2014; 183: 44-47
31 Karna E, Pałka J, Wołczyński S. Doxycycline-induced inhibition of prolidase activity in human skin fibroblasts and its involvement in impaired collagen biosynthesis. Eur J Pharmacol 2001; 430: 25-31
32 Panahi Y, Alishiri GH, Parvin S et al. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. J Diet Suppl 2015;
33 Claessen KM, Ramautar SR, Pereira AM et al. Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol 2012; 167: 235-244
34 Claessen KM, Ramautar SR, Pereira AM et al. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study. Pituitary 2014; 17: 44-52
35 Kropf LL, Madeira M, Vieira Neto L et al. Functional evaluation of the joints in acromegalic patients and associated factors. Clin Rheumatol 2013; 32: 991-998
36 Anagnostis P, Efstathiadou ZA, Gougoura S et al. Oxidative stress and reduced antioxidative status, along with endothelial dysfunction inacromegaly. Horm Metab Res 2013; 45: 314-318